CH 223191
CH-223191是一种有效的特定aryl hydrocarbon receptor (AhR)拮抗剂,IC50为30 nM。
-
货号:
TK0363 -
规格:
- 1mg
- 5mg
- 10mg
-
价格:
¥0.00
CH-223191是一种有效的特定aryl hydrocarbon receptor (AhR)拮抗剂,IC50为30 nM。
| CAS No. | 301326-22-7 |
| 生物活性 | CH-223191 is a potent and specific antagonist of aryl hydrocarbon receptor (AhR). CH-223191 inhibits TCDD-mediated nuclear translocation and DNA binding of AhR, and inhibits TCDD-induced luciferase activity with an IC50 of 0.03 μM. |
| 分子式 | C19H19N5O |
| 分子量 | 333.39 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存条件 | Powder -20°C 3 years |
| 溶解性数据 | DMSO : 125 mg/mL (374.94 mM; Need ultrasonic) |
| 体内研究 | CH-223191 (10 mg/kg; once a day; 25 days) suppresses cytochrome P450 1A1 expression and the intrahepatocyte fat content in liver, reduces activity of AST and ALT in TCDD-treated mice. |
| 体外研究 | CH-223191 (0.1-10 μM; pre-treated 1 hour) inhibits TCDD-caused cytochrome P450 1A1 mRNA expression in a in dose-dependent manner. CH-223191 (0.1-10 μM; pre-treated 1 hour) causes a concentration-dependent inhibition of TCDD-induced cytochrome P450 enzyme activity. |
| 文献 | •J Hazard Mater. 2020 Mar 5;385:121521. •Cell Death Dis. 2019 Jan 15;10(2):38. •EBioMedicine. 2021 Jan 30;64:103227. •Sci Total Environ. 2020 Jun 1;719:135097. •Mater Today Bio. January 2022, 100170. •Brain Behav Immun. 2020 Aug;88:471-481. •Chemosphere. 2018 Oct 23;216:372-378. •Cancers (Basel). 2020 Oct 10;12(10):2915. •Cancers. 2020 Aug 25;12(9):2411. •Int J Mol Sci. 2020 Feb 25;21(5):1579. •Phytomedicine. 14 September 2021, 153751. •Ecotox Environ Safe. 2020 Feb;189:109937. •Eur J Pharmacol. 5 December 2021, 174581. •Mol Immunol. 2020 Sep;125:178-186. •Toxicology. 2021 Sep 28;462:152965. •Toxicology. 2016 May 20;355-356:31-38. •Environ Toxicol. 2017 Oct;32(10):2316-2322. •Universitat Politècnica de València. 2021 Sep. |
| 纯度及产品资料 | 98% |